By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation 12/18/2014 10:07:37 AM
Synergy Pharmaceuticals Announces Positive Results Of SP-333 Phase 2 Trial In Patients With Opioid-Induced Constipation 11/19/2014 9:59:09 AM
Synergy Pharmaceuticals Reports Third Quarter 2014 Financial Results 11/11/2014 9:10:21 AM
Synergy Pharmaceuticals To Present At Credit Suisse 2014 Healthcare Conference 11/5/2014 10:01:30 AM
Synergy Pharmaceuticals Announces Issuance Of $200 Million Of 7.50% Convertible Senior Notes 11/4/2014 11:47:32 AM
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option 10/30/2014 12:50:40 PM
Synergy Pharmaceuticals Announces Private Offering Of Convertible Senior Notes 10/29/2014 10:42:53 AM
Synergy Pharmaceuticals Announces Pricing Of Private Offering Of $175 Million Of 7.50% Convertible Senior Notes 10/29/2014 8:37:31 AM
Synergy Pharmaceuticals Presents Positive Phase 2b Study Results For Plecanatide In Patients With Irritable Bowel Syndrome With Constipation 10/21/2014 11:30:40 AM
Synergy Pharmaceuticals To Present Additional Positive Phase 2b Study Results For Plecanatide In Patients With Irritable Bowel Syndrome With Constipation At American College of Gastroenterology 2014 Annual Scientific Meeting 10/7/2014 10:51:14 AM
12345678910...
//-->